S100B and melanoma: Serum LDH is an established prognostic factor in patients with advanced melanoma.<h4>Objective</h4>To compare the discriminative and prognostic ability of serum S100B with that of serum LDH in patients with melanoma.<h4>Methods</h4>This systematic review and meta-analysis were reported in accordance with the PRISMA Statement.